Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis

Yu Han, Wei Guo, Tingting Ren, +7

Cancer Letters

Lung MetastasisTumor-associated MacrophagesMedicinePathologyCox-2/stat3 Axis +7

Bone marrow mesenchymal stem cell-derived exosomal miR-206 inhibits osteosarcoma progression by targeting TRA2B

Hongliang Zhang, Jun Wang, Tingting Ren, +6

Cancer Letters

MedicineStem CellsPathologyMesenchymal Stem CellStem Cell Trafficking +5

Identification of Potential Therapeutic Targets and Immune Cell Infiltration Characteristics in Osteosarcoma Using Bioinformatics Strategy

Jianfang Niu, Taiqiang Yan, Wei Guo, +7

Frontiers in Oncology

Methylsulfonylmethane protects against lethal dose MRSA-induced sepsis through promoting M2 macrophage polarization

Wei Ma, Shengxiang Ao, Jianping Zhou, +3

Molecular Immunology

Macrophages reduce the sensitivity of osteosarcoma to neoadjuvant chemotherapy drugs by secreting Interleukin-1 beta

Xin Liang, Wei Guo, Tingting Ren, +6

Cancer Letters

InflammationCancer ImmunosurveillanceInterleukin-1 BetaMetronomic TherapyImmunology +7

Development of a prognostic gene signature based on an immunogenomic infiltration analysis of osteosarcoma

Yiyang Yu, Hongliang Zhang, Tingting Ren, +6

Journal of Cellular and Molecular Medicine

EngineeringImmunologyPathologyImmunotherapyTumor Biology +14

Apatinib plus ifosfamide and etoposide for relapsed or refractory osteosarcoma: A retrospective study in two centres

Lu Xie, Jie Xu, Xin Sun, +9

Oncology Letters

Surgical OncologyCancer ManagementPathologyApatinib 500Orthopaedic Surgery +18

<p>miR-100-5p Inhibits Malignant Behavior of Chordoma Cells by Targeting IGF1R</p>

Hongliang Zhang, Kang Yang, Tingting Ren, +8

Cancer Management and Research

ARTEMIS-002: Phase 2 study of HS-20093 in patients with relapsed or refractory osteosarcoma.

Lu Xie, Jie Xu, Xin Sun, +16

Journal of Clinical Oncology

Malignant DiseaseMedicineCancer ManagementImmunologyTumor Immunity +13

Exploratory study of an anti-PD-L1/TGF-β antibody, TQB2858, in patients with refractory or recurrent osteosarcoma and alveolar soft part sarcoma: a report from Chinese sarcoma study group (TQB2858-Ib-02)

Lu Xie, Xin Liang, Jie Xu, +9

BMC Cancer